Company Filing History:
Years Active: 2023-2025
Title: Mark Vander Wal: Innovator in CD73 Modulation
Introduction
Mark Vander Wal is a notable inventor based in Berkeley, California. He has made significant contributions to the field of biochemistry, particularly in the modulation of CD73. With a total of two patents to his name, Vander Wal is recognized for his innovative approaches to complex biochemical challenges.
Latest Patents
Vander Wal's latest patents include "Compounds and methods for CD73 modulation and indications therefor." These patents disclose compounds of Formula I, which are aimed at enhancing the understanding and treatment of various medical conditions through the modulation of CD73.
Career Highlights
Throughout his career, Vander Wal has been associated with Opna Bio SA, a company focused on advancing biopharmaceuticals. His work has been instrumental in developing new therapeutic strategies that leverage the modulation of CD73.
Collaborations
Vander Wal has collaborated with notable colleagues such as Songyuan Shi and John Buell. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Mark Vander Wal's contributions to the field of CD73 modulation exemplify the impact of innovative thinking in biochemistry. His patents and collaborations continue to pave the way for advancements in medical treatments.